Recombinant HIV-1 gp 41 Envelope Protein (VAng-0532Lsx)
HIV type 1 Glycoprotein 41 Envelope Antigen, recombinant protein from E. coli, MW 146 kDa with Beta-galactosidase (114 kDa), 1.00 mg/mL.
Datasheet
Specifications
Source
E. coli.
Target
Human Immunodeficiency Virus
Type
Viral Antigens
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
10 mM Sodium Carbonate (Na2CO3), 10 mM Ethylenediaminetetraacetic Acid (EDTA), 14 mM Beta-Mercaptoethanol (beta-ME), 0.05% Tween 20.
Purity
~95% pure by SDS-PAGE.
Storage
Store at 2°C to 8°C.
Antigen Information
Introduction
The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). HIV infect human which leads to paralysis of the immune system by destructing T lymphocytes, and then blocks processes of the cellular immune and humoral immune, eventually leads to AIDS. Recently, there are four HIV strains, named M, N, O and P type, all come from Cameroon chimpanzees and gorillas. Each of these four species has unique source, and we now know that the most widely spread of M and N have been confirmed from chimpanzees, while the rare O and P types have been confirmed from gorillas of southwestern Cameroon.
Alternative Names
env; Glycoprotein 41; gp41; TM; Transmembrane protein; HIV gp41 L
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
